RGC RGC
Company Profile ↓Company Overview
RGC (RGC) is a publicly traded company listed on with a market capitalization of $2.90B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -53.41% |
| 6 Months: | -79.37% |
| 3 Months: | -78.47% |
| 1 Month: | -1.34% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.33 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 88.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 7.62M | 6.27M | 4.74M | - |
| Operating Income | -7.62M | -6.27M | -4.74M | - |
| EBITDA | -7.01M | -5.50M | -3.99M | - |
| Interest Expense | - | - | - | - |
| Pretax Income | -7.59M | -6.06M | -4.36M | - |
| Tax Provision | 0 | 0 | 0 | - |
| Net Income | -7.45M | -5.87M | -4.30M | - |
| Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Total Assets | 18.02M | 12.62M | 8.44M |
| Current Assets | 16.44M | 11.62M | 8.11M |
| Cash & Equivalents | 6.42M | 1.56M | 2.96M |
| Inventory | - | - | - |
| Receivables | 27.60K | 56.55K | 152.78K |
| Total Liabilities | 938.03K | 632.32K | 219.51K |
| Current Liabilities | 577.76K | 606.91K | 193.58K |
| Long Term Debt | - | - | - |
| Total Debt | 771.25K | 463.67K | 85.74K |
| Total Equity | 17.07M | 12.03M | 8.22M |
| Shares Outstanding | 494.49M | 494.49M | 494.49M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Operating Cash Flow | -5.27M | -4.96M | -4.00M |
| Investing Cash Flow | -10.78M | 58.98K | 5.24M |
| Financing Cash Flow | 22.41M | 134.91K | 102.28K |
| Capital Expenditure | -780.88K | -27.39K | -5.38K |
| Free Cash Flow | -6.05M | -4.99M | -4.01M |
| Net Change in Cash | 6.36M | -4.77M | 1.34M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | - | - | - | - |
| ROE % | -43.6% | -48.8% | -52.3% | - |
| ROCE % | -43.7% | -52.2% | -57.5% | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RGC
RGC Shareholder Alert: June 23, 2026 Lead Plaintiff - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMiuAJBVV95cUxNOHc4YWYybEZ6d0VRMk10LTlwSWY0QXFXeXVyZ1FZeVduYlh5Nk9KLTJ0RGRnMG4tQXFneG14M3lFSHo5QjhjcGN3cElzUVFQeE1KWTJqalRNZGprZlh3Vm01MmVBc2lCRndvYlg5T0hKOFJNQ2lYLWtyVngyZXNZQW1kS181ejVJQzM4dT…
A Look At Regencell Bioscience Holdings (RGC) Valuation After Department Of Justice Investigation News - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxPellvbWI4ZV9INWwwQ0gyVkdPbjNsTVptbnR6S28zaDFNME9WQW1kb3lfMVdVZm14OEkyNVBCSGxRdnJSREFCRDZKY3kyODc5eUJ2ZHJNRUVhdnZPOVJEUjlZUmhlRVNCS2dfdVZUN2NoOHBmY1BzZG54bmp5bW1qVU91d2NiN3FTNHdEag…
RGC Deadline Alert: Levi & Korsinsky Reminds Regencell Bioscience Holdings (RGC) Investors of Securities Class Action Deadline on June 23, 2026 - PR Newswire
<a href="https://news.google.com/rss/articles/CBMinwJBVV95cUxOeVhRblJDRFZlT1ZSUkk2OFdTSTJwcndlbmFBME43M0cyUU9qQkQ2eUdwdENxX1RJemktYnZPWENVVTFOMG1sRDA2b3BvOXRHYTFFUmFGRWsxY05yMWtFbGJzSUx1N0RvbDhtQ1dLRG5mZEplVldESzF5NnZ0SWgzRm0wSjFMeHloWTF4b0…
RGC Resources to Review Fiscal Q3 Results in Aug. 7 Webcast - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOdzlsNTFkdHc4eWlhRFN6czJWeWhFdmZNbG05SnpveUZQYXN4dEoybHF0aDFzeFk1alNiR2ZLUzBaQ1FIVG1wQ1NPb21ES1lPNFFfV3Y4cjQtSExnVDdxd0xYaXVybEZzVTJnTHFwcEMxV182aU9fampQS2V5eS1ESm0zZmo4YTFxd0Z3WH…
Regencell Bioscience Holdings Limited Revenue Breakdown – NASDAQ:RGC - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE03NnJpbDdxLXZmOGdvNDI0OUtLU2ZzaTFzYlY5SzRvdFN2UzcwdWdtLXNLWUN4ZWhZZG5NeFJQTWhKeEpTMFNSOEVMcmNJNU5lRmh4Sm82ckZSQWVWQVJaOXJLZHlaMkwweTQyaExac1R2WVhTZlE?oc=5" target="_blank">Regencel…
Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential (NASDAQ:RGC) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPdEU3UTd6MVVCSzByU2pLT2JiRzFfUk5lS1ZVUDhveXBiQ1ZubjFWNjViMmhDZnFpVUJ2bFpPUXJWRmpuU3pCYnZMMXdLVlVlOC1abUxTOXg4ZzNPdlVwRUo5bzhNdmNBRzVxYlFIdGgwZ1FjeHUwWkdPdE9MSEIwdGhhY05CLWpWeXdWWW…
RGC — Frequently Asked Questions
What is the current share price of RGC?
As of 2026-08-05 17:25 PDT, RGC trades at $5.87 on NASDAQ/NYSE. Its 52-week range is $4.78 to $52.88.
What is the market capitalisation of RGC?
RGC has a market capitalisation of $2.90B on NASDAQ/NYSE.
What is the P/E ratio of RGC?
RGC trades at a trailing price-to-earnings (P/E) ratio of -815.28. Its price-to-book (P/B) ratio is 353.61.
What is the return on equity (ROE) of RGC?
RGC has a return on equity (ROE) of -52.34%. Its return on capital employed (ROCE) is -57.45%.
Is RGC a good stock to buy?
This page provides a data-driven analysis of RGC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.